Safe Cosmetics Act
This article was originally published in The Tan Sheet
Executive Summary
California's "Safe Cosmetics Act" (S.B. 484) which covers personal care products like toothpaste, antiperspirant and sunscreen, "will become a very dominant issue as we roll into 2007," United Natural Products Alliance Executive Director Loren Israelsen asserted at Expo West March 25. Israelsen warned of greater traffic to 1Skin Deep, the "online, brand-by-brand personal care product safety guide" maintained by the Washington, D.C.-based Environmental Working Group. EWG worked with other national non-profits that form the Campaign for Safe Cosmetics coalition to pass S.B 484. "You will see a tremendous education effort begin to invite" women to the database when the bill goes into effect in 2007, Israelsen predicted. Skin Deep ranks more than 14,400 products, searchable by brand name and type, by "relative concern." The ranking is based on a cross-reference of a product's ingredients with sources such as the National Toxicology Program and the Environmental Protection Agency. The Safe Cosmetics Act requires that firms report to the Department of Health the use of any chemicals known in any state to cause cancer or reproductive toxicity...
You may also be interested in...
California Court’s Inaction On TiO2 Prop 65 First Amendment Case Breeds New Lawsuits
The Personal Care Products Council seeks to stem the rising tide of titanium dioxide Proposition 65 lawsuits, requesting that a California court prohibit the state’s Attorney General and private enforcers from filing and/or prosecuting new suits against cosmetics companies failing to warn about potential TiO2 exposure.
Kenvue Breaks Ground On New Headquarters, Appoints Chief Corporate Affairs Officer
Firm hosts groundbreaking for 290,000 square-foot global headquarters it’s having built in Summit, NJ, starting with 100,000 square-foot science and innovation and expected to open in 2025. It announced adding Russell Dyer as chief corporate affairs officer starting 13 March.
Xaira Launches With $1bn-Plus And End-To-End AI Strategy
ARCH and Foresite incubated the company and recruited Genentech R&D veteran Marc Tessier-Lavigne to keep data generation, machine learning research and drug development under one roof.